Clinical Trial Update: Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial conducted by Institut Curie evaluating opsoclonus myoclonus syndrome in children with and without neuroblastoma; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma
• Opsoclonus Myoclonus Syndrome

Snippet

Sponsor: Institut Curie | Conditions: Opsoclonus Myoclonus Syndrome, Neuroblastoma | Phase 3 | Status: COMPLETED